Contec Medical (China) Performance
| 300869 Stock | 14.15 0.23 1.65% |
The firm shows a Beta (market volatility) of -0.42, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning Contec Medical are expected to decrease at a much lower rate. During the bear market, Contec Medical is likely to outperform the market. At this point, Contec Medical Systems has a negative expected return of -0.0366%. Please make sure to confirm Contec Medical's standard deviation, total risk alpha, maximum drawdown, as well as the relationship between the jensen alpha and treynor ratio , to decide if Contec Medical Systems performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
Very Weak
Weak | Strong |
Over the last 90 days Contec Medical Systems has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, Contec Medical is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors. ...more
Forward Dividend Yield 0.0212 | Payout Ratio 0.122 | Forward Dividend Rate 0.3 | Ex Dividend Date 2024-05-29 |
| Begin Period Cash Flow | 1.4 B | |
| Free Cash Flow | 257.9 M |
Contec |
Contec Medical Relative Risk vs. Return Landscape
If you would invest 1,459 in Contec Medical Systems on December 27, 2024 and sell it today you would lose (44.00) from holding Contec Medical Systems or give up 3.02% of portfolio value over 90 days. Contec Medical Systems is generating negative expected returns and assumes 1.864% volatility on return distribution over the 90 days horizon. Simply put, 16% of stocks are less volatile than Contec, and 99% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
Contec Medical Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Contec Medical's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Contec Medical Systems, and traders can use it to determine the average amount a Contec Medical's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.0197
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | 300869 |
Estimated Market Risk
| 1.86 actual daily | 16 84% of assets are more volatile |
Expected Return
| -0.04 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.02 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Contec Medical is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Contec Medical by adding Contec Medical to a well-diversified portfolio.
Contec Medical Fundamentals Growth
Contec Stock prices reflect investors' perceptions of the future prospects and financial health of Contec Medical, and Contec Medical fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Contec Stock performance.
| Return On Equity | -0.0097 | ||||
| Return On Asset | -0.0102 | ||||
| Profit Margin | (0.04) % | ||||
| Operating Margin | 0.11 % | ||||
| Current Valuation | 5.28 B | ||||
| Shares Outstanding | 401.8 M | ||||
| Price To Book | 2.94 X | ||||
| Price To Sales | 12.33 X | ||||
| Revenue | 734.05 M | ||||
| Gross Profit | 194.71 M | ||||
| EBITDA | 136.65 M | ||||
| Net Income | 165.77 M | ||||
| Total Debt | 1.05 B | ||||
| Book Value Per Share | 4.81 X | ||||
| Cash Flow From Operations | 288.68 M | ||||
| Earnings Per Share | (0.05) X | ||||
| Total Asset | 3.22 B | ||||
| Retained Earnings | 1.09 B | ||||
About Contec Medical Performance
By analyzing Contec Medical's fundamental ratios, stakeholders can gain valuable insights into Contec Medical's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Contec Medical has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Contec Medical has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Contec Medical is entity of China. It is traded as Stock on SHE exchange.Things to note about Contec Medical Systems performance evaluation
Checking the ongoing alerts about Contec Medical for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Contec Medical Systems help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Contec Medical generated a negative expected return over the last 90 days | |
| About 62.0% of the company shares are owned by insiders or employees |
- Analyzing Contec Medical's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Contec Medical's stock is overvalued or undervalued compared to its peers.
- Examining Contec Medical's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Contec Medical's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Contec Medical's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Contec Medical's stock. These opinions can provide insight into Contec Medical's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Contec Stock analysis
When running Contec Medical's price analysis, check to measure Contec Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Contec Medical is operating at the current time. Most of Contec Medical's value examination focuses on studying past and present price action to predict the probability of Contec Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Contec Medical's price. Additionally, you may evaluate how the addition of Contec Medical to your portfolios can decrease your overall portfolio volatility.
| Transaction History View history of all your transactions and understand their impact on performance | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing |